Position in DXCM
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,346,284
+$454,910 QoQ
Shares Held
49,685
+7.9% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#321
of 966 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026J. Safra Sarasin Holding AG holds $15,888,528 across 9 Medical Devices names. DXCM ranks #2 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
117,689 | $5,022,964 | |
| 2 | DXCM |
Dexcom Inc
This page
|
49,685 | $3,346,284 | |
| 3 | ZBH |
Zimmer Biomet Holdings, Inc.
|
18,974 | $1,633,470 | |
| 4 | ABT |
Abbott Laboratories
|
16,723 | $1,517,444 | |
| 5 | SYK |
Stryker Corp
|
3,719 | $1,170,889 | |
| 6 | EW |
Edwards Lifesciences Corp
|
11,847 | $1,071,678 | |
| 7 | PODD |
Insulet Corp
|
6,403 | $974,856 | |
| 8 | MDT |
Medtronic plc
|
8,567 | $670,196 |
All Filings in DXCM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,346,284 | 49,685 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $2,891,374 | 46,041 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $2,408,102 | 36,283 | Shares | Defined | 2026-01-15 | |
| 2025-09-30 | $1,546,593 | 22,984 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $3,541,791 | 40,575 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $1,091,615 | 15,985 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $2,766,667 | 35,575 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,390,753 | 80,411 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,198,823 | 54,673 | Shares | Defined | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||